NCT02378532 The Addition of Chloroquine to Chemoradiation for Glioblastoma Status COMPLETED Phase PHASE1
NCT02365662 A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor Status TERMINATED Phase PHASE1
NCT02344355 A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02331498 Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02296580 A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) Status COMPLETED Phase NA
NCT02296476 A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002) Status TERMINATED Phase PHASE2
NCT02286167 Glioma Modified Atkins-based Diet in Patients With Glioblastoma Status COMPLETED Phase NA
NCT02285959 Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme Status UNKNOWN Phase PHASE1
NCT02223052 Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT02189109 The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma Status COMPLETED Phase PHASE1
NCT02177578 Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02176720 Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma Status TERMINATED Phase PHASE1
NCT02146066 Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 Status AVAILABLE Phase N/A
NCT02120287 Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT02104882 INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study Status COMPLETED Phase PHASE1/PHASE2
NCT02078648 Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme Status COMPLETED Phase PHASE1/PHASE2
NCT02067156 Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma Status COMPLETED Phase PHASE2
NCT02060955 Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan Status TERMINATED Phase PHASE2
NCT02052648 Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors Status COMPLETED Phase PHASE1/PHASE2